The company's merger with Aphria closed in May, but investors shouldn't rule out another one in the near future.
Cannabis company Tilray (NASDAQ:TLRY) is hoping to reach $4 billion in annual revenue by 2024. For a company that is currently at a run rate of less than $700 million -- it has a long way to go in reaching that target.